Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: Our World in Data; Chart: Axios Visuals

Brutal surges in coronavirus cases are hitting much of the world all at once, from Europe to Brazil to India.

The big picture: Cases are rising just about everywhere, in a swift reversal from early February, when they were falling on every continent. They're also now ticking up in the U.S., which is in the midst of a race between vaccines and variants.

  • Brazil is recording by far the world's highest daily death tolls, which far exceed anything seen earlier in the pandemic. Hospitals are at or exceeding capacity in nearly every state, AP reports. A new, more contagious “Brazilian variant” poses a grave threat, including to the U.S.
  • Nairobi, Kenya, has entered a partial lockdown, with schools and bars closed and domestic travel halted. Recorded cases and deaths in Kenya remain relatively low, but high test positivity rates and surging hospital admissions have alarmed the government.
  • German officials are warning that the third wave there could be the most devastating yet.

Go deeper: CDC director warns of "impending doom"

Go deeper

Mar 29, 2021 - Health

CDC director warns of "impending doom" as COVID cases increase

Centers for Disease Control and Prevention Director Rochelle Walensky went off script at a briefing Monday and made an emotional plea to Americans not to let up on public health measures amid fears of a fourth wave.

What they're saying: “I'm going to reflect on the recurring feeling I have of impending doom," Walensky said, appearing to hold back tears. "We do not have the luxury of inaction. For the health of our country, we must work together now to prevent a fourth surge."

Mar 29, 2021 - Health

Millions of Americans remain vulnerable as variants drive up cases

Illustration: Sarah Grillo/Axios

Coronavirus cases are on the rise again in several states, partially a result of variants of the virus becoming more widespread, experts say.

Why it matters: Even though a remarkable 72% of Americans 65 and older have received at least one dose of the vaccine, millions of Americans — particularly younger Americans with underlying conditions — remain vulnerable.

Mar 29, 2021 - Health

CDC: Pfizer, Moderna vaccines are 90% effective in real-world conditions

A registered nurse loads a syringe with a dose of the Pfizer COVID-19 vaccine. Photo: Frederic Brown/AFP via Getty Images

People who are fully vaccinated with the mRNA vaccines from Pfizer or Moderna are 90% less likely to get infected with COVID-19, according to a CDC study that tested nearly 4,000 health care workers and other essential workers for the virus weekly.

Why it matters: The data show how well the vaccine performs in non-clinical trial settings. During the mRNA clinical trials for both the Pfizer and Moderna vaccines, effectiveness from full vaccination was about 95%.